Showing results (11-20 of 61) with videos related to
Sort By:
Pageof 7
Diabetes, Obesity & Metabolism|December 3, 2020
Mechanism of action of Imeglimin: A novel therapeutic agent for type 2 diabetesSophie Hallakou-Bozec, Guillaume Vial, Micheline Kergoat, et al.European Journal of Pharmacology|April 16, 2003
A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growthDennis Bruemmer, Joel P Berger, Joey Liu, et al.Endocrinology|August 7, 2004
Small-molecule insulin mimetic reduces hyperglycemia and obesity in a nongenetic mouse model of type 2 diabetesMathias Z Strowski, Zhihua Li, Deborah Szalkowski, et al.Brain Research|May 24, 2003
Localization of PPARdelta in murine central nervous system: expression in oligodendrocytes and neuronsJohn W Woods, Michael Tanen, David J Figueroa, et al.Endocrinology|August 9, 2008
Fibroblast growth factor 21 corrects obesity in miceTamer Coskun, Holly A Bina, Michael A Schneider, et al.Kidney International|February 22, 2023
A novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of Autosomal Dominant Polycystic Kidney DiseasePascale Gluais Dagorn, Bjoern Buchholz, Andre Kraus, et al.Bioorganic & Medicinal Chemistry Letters|March 6, 2003
Amphipathic 3-phenyl-7-propylbenzisoxazoles; human pPaR gamma, delta and alpha agonistsAlan D Adams, Winston Yuen, Zao Hu, et al.Journal of Medicinal Chemistry|April 2, 2005
Discovery of a novel series of peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes and dyslipidemiaKun Liu, Libo Xu, Joel P Berger, et al.Cell Reports. Medicine|January 14, 2022
Pharmacodynamic effects of direct AMP kinase activation in humans with insulin resistance and non-alcoholic fatty liver disease: A phase 1b studyPascale Fouqueray, Sebastien Bolze, Julie Dubourg, et al.Proceedings of the National Academy of Sciences of the United States of America|February 28, 2003
Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipaseOuliana Ziouzenkova, Stephane Perrey, Liana Asatryan, et al.Pageof 7